Skye Bioscience, Inc. (SKYE) - Latest Market Data

Price & Market Data

Price: $0.822

Daily Change: -$0.0585 / 7.12%

Daily Range: $0.802 - $0.904

Market Cap: $28,589,416

Daily Volume: 118,873

Performance Metrics

1 Week: -7.26%

1 Month: 12.53%

3 Months: 12.94%

6 Months: -46.83%

1 Year: -60.32%

YTD: 8.51%

About Skye Bioscience, Inc. (SKYE)

Understand Skye Bioscience, Inc. (SKYE)'s current market standing. Current price: 0.822, daily change: -$0.0585 / 7.12%. Market cap: 28,589,416. Detailed performance for all periods.

Company Details

Employees: 12

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.

Selected stocks

ConAgra Brands, Inc. (CAG)

Twelve Seas Investment Company III (TWLVU)

Nu Skin Enterprises, Inc. (NUS)

Gores Holdings X, Inc. (GTEN)